Journal Club 2026

Next HOPA Journal Club

Thursday, September 17, 2026 at 12 p.m. Central Time

Listen to critical evaluations of hematology/oncology pharmacy publications presented by PGY2 Oncology Residents.

Orange button that says click here to register

The moderator for September's Journal Club session is:

Sara Fleszar, PharmD, BCOP, Senior Clinical Oncology Pharmacist, Optum Whole Health Solutions, Denver, CO

September's Journal Club presenters include:

Morgan Irvin, PharmD

PGY2 Oncology Pharmacy Resident

University of New Mexico Hospitals, Albuquerque, NM

Article:

Transdermal Estradiol Patches in Locally Advanced Prostate Cancer

Tyler Philipps, PharmD

PGY2 Oncology Pharmacy Resident

UW Health, Madison, WI

Article:

Daraxonrasib or Chemotherapy in Previously Treated Metastatic Pancreatic Cancer

Featured Articles

HOPA News

Late-Breaking HOPA News: RASolute 302 Breakthrough in Metastatic Pancreatic Adenocarcinoma

August 05, 2026

Michael Arnold, PharmD, discusses the very encouraging results from the RASolute 302 trial, a potential breakthrough in pancreatic cancer threapy.

HOPA News

Late-Breaking HOPA News: Precision-T: Orca-T and the Evolution of GVHD Prophylaxis in Allogeneic Transplantation

August 04, 2026

Nathan Schieldt, PharmD, BCOP, discusses allogeneic hematopoietic stem cell transplantation's place as a potentially curative therapy for high-risk hematologic malignancies and how Orca-T provides a novel approach to allo-HSCT.

Tools and Resources

Pharmacist's Application to Practice: Amivantamab and Hyaluronidase-lpuj

June 01, 2026

Mealis Taouk, PharmD, PGY2 Oncology Pharmacy Resident, and Karen Abboud, PharmD, BCPS, BCOP - both from Houston Methodist Hospital in Houston, TX - write about amivantamab and hyaluronidase-lpuj (Rybrevant Faspro).